Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: breakdown (61), malfunction (2), crash (13), collapse (38), disappointment (5)

Papers Trust Board - 13 January 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education Ce
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Quality account 24-25 final

Description: QUALITY ACCOUNT 2024/25 QUALITY ACCOUNT Contents Part 1: Statement on quality from the chief executive 1.1 Chief executive’s statement
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/quality-account-24-25-final1.pdf

Lenvatinib

Description: Chemotherapy Protocol THYROID CANCER LENVATINIB Regimen • Thyroid – Lenvatinib Indication • The treatment of differentiated thyroid cancer afte
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Lenvatinib.pdf

Symptom and consequence: not interchangeable

Description: A court considers whether a patient with fluctuating capacity should be compelled to have haemodialysis at times when he refuses it
Url: /HealthProfessionals/Clinical-law-updates/Symptom-and-consequence-not-interchangeable.aspx

Eye expert warns 'misconception' among surgeons causing sight loss

Description: A leading eye expert has warned some patients in the UK may be losing their sight unnecessarily due to a "poor
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/December-2017/Eye-expert-warns-misconception-among-surgeons-causing-sight-loss.aspx

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituxima
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

Papers Trust Board 6 June 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 06/06/2024 9:00 - 13:00 Conference Room, Heartbeat/Microsoft
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-6-June-2024.pdf

UHS Patient safety incident response plan

Description: Patient safety incident response plan Effective date: 2nd October 2023 Estimated refresh date:2nd October 2024 with informal review
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Patient-safety-incident-response-plan.pdf

Annual report 2021-2022

Description: 2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

Parenteral nutrition - patient information

Description: This factsheet explains what parenteral nutrition is, why you might need it and the possible risks of having it.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Parenteral-nutrition-2707-PIL.pdf

21 to 30 of 361

Previous 1 2 3 4 5 … Next